Next 10 |
U.S. Food and Drug Administration Grants Regulatory Clearance to IceCure for Next-Gen XSense™ Cryoablation System with CryoProbes PR Newswire CAESAREA, Israel , July 1, 2024 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medic...
IceCure Medical to Provide Overview and Share Recent Progress at Northland Capital Markets Virtual Growth Conference on June 25, 2024 PR Newswire Recent insider open-market stock purchases demonstrate continued confidence in the Company CAESAREA, Israel , ...
Positive Data from IceCure's Kidney Cancer Clinical Study Presented at Interventional Radiology Conference: Minimally Invasive Approach Results in Shorter Hospitalization and Minor Impact on Renal Function PR Newswire ICESECRET interim results, as previously announced, dem...
FDA to Convene Advisory Panel for Review of IceCure's De Novo Marketing Clearance Request for ProSense®, Decision Expected Early 2025; Aligns with Commercial Readiness Plan PR Newswire Demonstrates public health importance of assessing ProSense®'s potential ...
2024-05-28 17:06:03 ET IceCure Medical Ltd (ICCM) Q1 2024 Earnings Conference Call May 28, 2024, 11:00 AM ET Company Participants Michael Polyviou - Investor Relations Eyal Shamir - Chief Executive Officer Tlalit Bussi Tel-Tzure - VP, Business Development & G...
2024-05-28 08:39:37 ET More on IceCure Medical Seeking Alpha’s Quant Rating on IceCure Medical Historical earnings data for IceCure Medical Financial information for IceCure Medical Read the full article on Seeking Alpha For further details see...
IceCure Medical Maintains Positive Momentum and Reports Sales Growth for Cryoablation System in First Quarter of 2024 PR Newswire 30% sales growth reflects continued adoption of ProSense® in the U.S. and other global markets Major milestones achieved:...
Orkla ASA ADR (ORKLY) is expected to report for Q1 2024 Cosmos Health Inc. (COSM) is expected to report $-0.14 for Q1 2024 Basilea Pharmaceutica AG Registered Shares (BPMUF) is expected to report for Q1 2024 DCC Plc (DCCPF) is expected to report for Q4 2024 Datatec Ltd ADR (DTTLY)...
IceCure Medical to Report First Quarter 2024 Financial & Operational Results on May 28, 2024 IceCure Medical to Report First Quarter 2024 Financial & Operational Results on May 28, 2024 PR Newswire CAESAREA, Israel , May 21, 2024 /PRNewswire/ -- Ice...
IceCure Medical to Highlight Key Achievements and Provide Business Overview at A.G.P. / Alliance Global Partners' Virtual Healthcare Company Showcase PR Newswire CAESAREA, Israel , May 20, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or...
News, Short Squeeze, Breakout and More Instantly...
U.S. Food and Drug Administration Grants Regulatory Clearance to IceCure for Next-Gen XSense™ Cryoablation System with CryoProbes PR Newswire CAESAREA, Israel , July 1, 2024 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medic...
IceCure Medical to Provide Overview and Share Recent Progress at Northland Capital Markets Virtual Growth Conference on June 25, 2024 PR Newswire Recent insider open-market stock purchases demonstrate continued confidence in the Company CAESAREA, Israel , ...
Positive Data from IceCure's Kidney Cancer Clinical Study Presented at Interventional Radiology Conference: Minimally Invasive Approach Results in Shorter Hospitalization and Minor Impact on Renal Function PR Newswire ICESECRET interim results, as previously announced, dem...